Synthetic Minds | Surgery, Drugs and Biosecurity Share the Same Brain
Nvidia has shipped the first commercially licensed surgical AI brain to robot makers. Jazz Pharmaceuticals has committed up to $2.46 billion and Merck up to $510 million to two AI antibody platforms. BARDA has closed its window on AI antivirals. The substrate of medicine has been quietly outsourced.
Read More